PPAR Research

Smad2/3 Upregulates the Expression of Vimentin and Affects Its Distribution in DBP-Exposed Sertoli Cells

PPARs: Protectors or Opponents of Myocardial Function?

PPARγ and the Innate Immune System Mediate the Resolution of Inflammation

Zebrafish as a Model to Study the Role of Peroxisome Proliferating-Activated Receptors in Adipogenesis and Obesity

PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia

Treatment with PPARα Agonist Clofibrate Inhibits the Transcription and Activation of SREBPs and Reduces Triglyceride and Cholesterol Levels in Liver of Broiler Chickens

AICAR Protects against High Palmitate/High Insulin-Induced Intramyocellular Lipid Accumulation and Insulin Resistance in HL-1 Cardiac Cells by Inducing PPAR-Target Gene Expression

Restoration of Endothelial Function in Pparα^−/− Mice by Tempol

PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice

Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions

Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease

15-Deoxy-Δ^12,14-Prostaglandin J₂ Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox Pathway

Identification of Bexarotene as a PPAR Antagonist with HDX

Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism

Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?

PPAR Research

Table of Contents

Table of Contents: 2015

Smad2/3 Upregulates the Expression of Vimentin and Affects Its Distribution in DBP-Exposed Sertoli Cells

PPARs: Protectors or Opponents of Myocardial Function?

PPARγ and the Innate Immune System Mediate the Resolution of Inflammation

Zebrafish as a Model to Study the Role of Peroxisome Proliferating-Activated Receptors in Adipogenesis and Obesity

PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia

Treatment with PPARα Agonist Clofibrate Inhibits the Transcription and Activation of SREBPs and Reduces Triglyceride and Cholesterol Levels in Liver of Broiler Chickens

AICAR Protects against High Palmitate/High Insulin-Induced Intramyocellular Lipid Accumulation and Insulin Resistance in HL-1 Cardiac Cells by Inducing PPAR-Target Gene Expression

Restoration of Endothelial Function in Pparα^−/− Mice by Tempol

PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice

Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions

Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease

15-Deoxy-Δ^12,14-Prostaglandin J₂ Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox Pathway

Identification of Bexarotene as a PPAR Antagonist with HDX

Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism

Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?

PPAR Research

Table of Contents

Table of Contents: 2015

Smad2/3 Upregulates the Expression of Vimentin and Affects Its Distribution in DBP-Exposed Sertoli Cells

PPARs: Protectors or Opponents of Myocardial Function?

PPARγ and the Innate Immune System Mediate the Resolution of Inflammation

Zebrafish as a Model to Study the Role of Peroxisome Proliferating-Activated Receptors in Adipogenesis and Obesity

PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia

Treatment with PPARα Agonist Clofibrate Inhibits the Transcription and Activation of SREBPs and Reduces Triglyceride and Cholesterol Levels in Liver of Broiler Chickens

AICAR Protects against High Palmitate/High Insulin-Induced Intramyocellular Lipid Accumulation and Insulin Resistance in HL-1 Cardiac Cells by Inducing PPAR-Target Gene Expression

Restoration of Endothelial Function in Pparα−/− Mice by Tempol

PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice

Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions

Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease

15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox Pathway

Identification of Bexarotene as a PPAR Antagonist with HDX

Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism

Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?

Restoration of Endothelial Function in Pparα^−/− Mice by Tempol

15-Deoxy-Δ^12,14-Prostaglandin J₂ Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox Pathway